重新利用药物和其他熟悉来源的新结果

Microbe (Washington, D.C.) Pub Date : 2016-05-01 DOI:10.1128/microbe.11.193.1

J. Fox

{"title":"重新利用药物和其他熟悉来源的新结果","authors":"J. Fox","doi":"10.1128/microbe.11.193.1","DOIUrl":null,"url":null,"abstract":"In the face of new and emerging infectious disease threats, it is prudent to look back at old or even ancient sources to uncover a drug or entity that might work anew or in a different context, according to several researchers who spoke during the 2016 ASM Biodefense and Emerging Diseases Research Meeting last February. Here, let us consider the old in three specific ways: revisiting licensed drugs, using old phage for new purposes, and looking at old beasts for new antimicrobials.","PeriodicalId":87479,"journal":{"name":"Microbe (Washington, D.C.)","volume":"11 1","pages":"193-194"},"PeriodicalIF":0.0000,"publicationDate":"2016-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Repurposing Drugs, and Fresh Outcomes from Other Familiar Sources\",\"authors\":\"J. Fox\",\"doi\":\"10.1128/microbe.11.193.1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In the face of new and emerging infectious disease threats, it is prudent to look back at old or even ancient sources to uncover a drug or entity that might work anew or in a different context, according to several researchers who spoke during the 2016 ASM Biodefense and Emerging Diseases Research Meeting last February. Here, let us consider the old in three specific ways: revisiting licensed drugs, using old phage for new purposes, and looking at old beasts for new antimicrobials.\",\"PeriodicalId\":87479,\"journal\":{\"name\":\"Microbe (Washington, D.C.)\",\"volume\":\"11 1\",\"pages\":\"193-194\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Microbe (Washington, D.C.)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1128/microbe.11.193.1\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microbe (Washington, D.C.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1128/microbe.11.193.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

去年2月，在2016年ASM生物防御和新兴疾病研究会议上发言的几位研究人员表示，面对新的和新兴的传染病威胁，回顾旧的甚至古老的来源，以发现可能在新的或不同的背景下起作用的药物或实体，是谨慎的。在这里，让我们以三种具体的方式来考虑旧的:重新审视已获许可的药物，将旧的噬菌体用于新的目的，以及从旧的野兽中寻找新的抗菌剂。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Repurposing Drugs, and Fresh Outcomes from Other Familiar Sources

In the face of new and emerging infectious disease threats, it is prudent to look back at old or even ancient sources to uncover a drug or entity that might work anew or in a different context, according to several researchers who spoke during the 2016 ASM Biodefense and Emerging Diseases Research Meeting last February. Here, let us consider the old in three specific ways: revisiting licensed drugs, using old phage for new purposes, and looking at old beasts for new antimicrobials.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Microbe (Washington, D.C.)

自引率

0.00%

发文量